ASTCT

View full entity profile (contributions, contracts, SEC) →

Lobbying Spend

—

Filings

Firms Hired

Active Period

2019–2026

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2026	—	3	1
2025	—	4	1
2024	—	4	1
2023	—	4	1
2022	—	4	1
2021	—	4	1
2020	—	6	1
2019	—	5	1

Hired Firms

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
SmithBucklin Corporation	—	34

Government Bodies Lobbied

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
Centers For Medicare and Medicaid Services (CMS)	33
HOUSE OF REPRESENTATIVES	33
SENATE	33
Centers For Disease Control & Prevention (CDC)	21
Food & Drug Administration (FDA)	15
Health & Human Services, Dept of (HHS)	11
Natl Institutes of Health (NIH)	9

Top Issues

Most frequently reported lobbying issues

Issue Code	Description	Reports
Medicare/Medicaid	Medicare/Medicaid	34
Health Issues	Health Issues	34
Medical/Disease Research/Clinical Labs	Medical/Disease Research/Clinical Labs	34
Pharmacy	Pharmacy	1
Government Issues	Government Issues	1
Insurance	Insurance	1
Education	Education	1

Bills Explicitly Cited (25)

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

H.R. 1262119th Congress

Mikaela Naylon Give Kids a Chance Act

2026 · third_quarter · Firm: SmithBucklin Corporation

Open original LDA filing ↗

Cited source text and reported amounts

Labor-HHS Appropriations Billing and Coding classifications CAR-T Therapy Clarifications OMB Uniform Guidance Oversight H.R. 2491/S. 1227, Alleviating Barriers to Care Act H.R. 5160/S.4109, the Stem Cell Therapeutic and Research Reauthorization Act of 2025 H.R.1262/S.932, the Give Kids a Chance Act S. 4440/H.R. 3521 - The Clinical Trial Modernization Act

Client expense: — · Firm income: $70,000

Matched citations: H.R.1262

H.R. 2491119th Congress

ABC Act

2026 · third_quarter · Firm: SmithBucklin Corporation

Open original LDA filing ↗

Cited source text and reported amounts

Labor-HHS Appropriations Billing and Coding classifications CAR-T Therapy Clarifications OMB Uniform Guidance Oversight H.R. 2491/S. 1227, Alleviating Barriers to Care Act H.R. 5160/S.4109, the Stem Cell Therapeutic and Research Reauthorization Act of 2025 H.R.1262/S.932, the Give Kids a Chance Act S. 4440/H.R. 3521 - The Clinical Trial Modernization Act

Client expense: — · Firm income: $70,000

Matched citations: H.R. 2491

H.R. 2491119th Congress

ABC Act

2026 · third_quarter · Firm: SmithBucklin Corporation

Open original LDA filing ↗

Cited source text and reported amounts

- CMS coding and billing clarity for CAR-T therapies - CMS engagement on MS-DRG 018 for CAR-T therapies - H.R. 2491/S. 1227, the Alleviating Barriers to Care Act

Client expense: — · Firm income: $70,000

Matched citations: H.R. 2491

H.R. 3521119th Congress

Clinical Trial Modernization Act

2026 · third_quarter · Firm: SmithBucklin Corporation

Open original LDA filing ↗

Cited source text and reported amounts

Labor-HHS Appropriations Billing and Coding classifications CAR-T Therapy Clarifications OMB Uniform Guidance Oversight H.R. 2491/S. 1227, Alleviating Barriers to Care Act H.R. 5160/S.4109, the Stem Cell Therapeutic and Research Reauthorization Act of 2025 H.R.1262/S.932, the Give Kids a Chance Act S. 4440/H.R. 3521 - The Clinical Trial Modernization Act

Client expense: — · Firm income: $70,000

Matched citations: H.R. 3521

Show 21 more cited filings

H.R. 3521119th Congress

Clinical Trial Modernization Act

2026 · third_quarter · Firm: SmithBucklin Corporation

Open original LDA filing ↗

Cited source text and reported amounts

- Labor-HHS Appropriations - CAR-T Therapy clarification - S. 4440/H.R. 3521, the Clinical Trial Modernization Act - OMB Uniform Guidance Oversight

Client expense: — · Firm income: $70,000

Matched citations: H.R. 3521

H.R. 5160119th Congress

Stem Cell Therapeutic and Research Reauthorization Act of 2025

2026 · third_quarter · Firm: SmithBucklin Corporation

Open original LDA filing ↗

Cited source text and reported amounts

Labor-HHS Appropriations Billing and Coding classifications CAR-T Therapy Clarifications OMB Uniform Guidance Oversight H.R. 2491/S. 1227, Alleviating Barriers to Care Act H.R. 5160/S.4109, the Stem Cell Therapeutic and Research Reauthorization Act of 2025 H.R.1262/S.932, the Give Kids a Chance Act S. 4440/H.R. 3521 - The Clinical Trial Modernization Act

Client expense: — · Firm income: $70,000

Matched citations: H.R. 5160

S. 1227119th Congress

ABC Act

2026 · third_quarter · Firm: SmithBucklin Corporation

Open original LDA filing ↗

Cited source text and reported amounts

Labor-HHS Appropriations Billing and Coding classifications CAR-T Therapy Clarifications OMB Uniform Guidance Oversight H.R. 2491/S. 1227, Alleviating Barriers to Care Act H.R. 5160/S.4109, the Stem Cell Therapeutic and Research Reauthorization Act of 2025 H.R.1262/S.932, the Give Kids a Chance Act S. 4440/H.R. 3521 - The Clinical Trial Modernization Act

Client expense: — · Firm income: $70,000

Matched citations: S. 1227

S. 1227119th Congress

ABC Act

2026 · third_quarter · Firm: SmithBucklin Corporation

Open original LDA filing ↗

Cited source text and reported amounts

- CMS coding and billing clarity for CAR-T therapies - CMS engagement on MS-DRG 018 for CAR-T therapies - H.R. 2491/S. 1227, the Alleviating Barriers to Care Act

Client expense: — · Firm income: $70,000

Matched citations: S. 1227

S. 4109119th Congress

Stem Cell Therapeutic and Research Reauthorization Act of 2026

2026 · third_quarter · Firm: SmithBucklin Corporation

Open original LDA filing ↗

Cited source text and reported amounts

Labor-HHS Appropriations Billing and Coding classifications CAR-T Therapy Clarifications OMB Uniform Guidance Oversight H.R. 2491/S. 1227, Alleviating Barriers to Care Act H.R. 5160/S.4109, the Stem Cell Therapeutic and Research Reauthorization Act of 2025 H.R.1262/S.932, the Give Kids a Chance Act S. 4440/H.R. 3521 - The Clinical Trial Modernization Act

Client expense: — · Firm income: $70,000

Matched citations: S.4109

S. 4440119th Congress

Clinical Trial Modernization Act

2026 · third_quarter · Firm: SmithBucklin Corporation

Open original LDA filing ↗

Cited source text and reported amounts

Labor-HHS Appropriations Billing and Coding classifications CAR-T Therapy Clarifications OMB Uniform Guidance Oversight H.R. 2491/S. 1227, Alleviating Barriers to Care Act H.R. 5160/S.4109, the Stem Cell Therapeutic and Research Reauthorization Act of 2025 H.R.1262/S.932, the Give Kids a Chance Act S. 4440/H.R. 3521 - The Clinical Trial Modernization Act

Client expense: — · Firm income: $70,000

Matched citations: S. 4440

S. 4440119th Congress

Clinical Trial Modernization Act

2026 · third_quarter · Firm: SmithBucklin Corporation

Open original LDA filing ↗

Cited source text and reported amounts

- Labor-HHS Appropriations - CAR-T Therapy clarification - S. 4440/H.R. 3521, the Clinical Trial Modernization Act - OMB Uniform Guidance Oversight

Client expense: — · Firm income: $70,000

Matched citations: S. 4440

S. 932119th Congress

Give Kids a Chance Act of 2025

2026 · third_quarter · Firm: SmithBucklin Corporation

Open original LDA filing ↗

Cited source text and reported amounts

Labor-HHS Appropriations Billing and Coding classifications CAR-T Therapy Clarifications OMB Uniform Guidance Oversight H.R. 2491/S. 1227, Alleviating Barriers to Care Act H.R. 5160/S.4109, the Stem Cell Therapeutic and Research Reauthorization Act of 2025 H.R.1262/S.932, the Give Kids a Chance Act S. 4440/H.R. 3521 - The Clinical Trial Modernization Act

Client expense: — · Firm income: $70,000

Matched citations: S.932

H.R. 1262119th Congress

Mikaela Naylon Give Kids a Chance Act

2026 · second_quarter · Firm: SmithBucklin Corporation

Open original LDA filing ↗

Cited source text and reported amounts

Labor-HHS Appropriations Billing and Coding classifications CAR-T Therapy Clarifications H.R. 2491/S. 1227, Alleviating Barriers to Care Act H.R. 5160/S.4109, the Stem Cell Therapeutic and Research Reauthorization Act of 2025 H.R.1262/S.932, the Give Kids a Chance Act S. 4440/H.R. 3521 - The Clinical Trial Modernization Act

Client expense: — · Firm income: $70,000

Matched citations: H.R.1262

H.R. 2491119th Congress

ABC Act

2026 · second_quarter · Firm: SmithBucklin Corporation

Open original LDA filing ↗

Cited source text and reported amounts

- CMS coding and billing clarity for CAR-T therapies - CMS engagement on MS-DRG 018 for CAR-T therapies - H.R. 2491/S. 1227, the Alleviating Barriers to Care Act

Client expense: — · Firm income: $70,000

Matched citations: H.R. 2491

H.R. 2491119th Congress

ABC Act

2026 · second_quarter · Firm: SmithBucklin Corporation

Open original LDA filing ↗

Cited source text and reported amounts

Labor-HHS Appropriations Billing and Coding classifications CAR-T Therapy Clarifications H.R. 2491/S. 1227, Alleviating Barriers to Care Act H.R. 5160/S.4109, the Stem Cell Therapeutic and Research Reauthorization Act of 2025 H.R.1262/S.932, the Give Kids a Chance Act S. 4440/H.R. 3521 - The Clinical Trial Modernization Act

Client expense: — · Firm income: $70,000

Matched citations: H.R. 2491

H.R. 3521119th Congress

Clinical Trial Modernization Act

2026 · second_quarter · Firm: SmithBucklin Corporation

Open original LDA filing ↗

Cited source text and reported amounts

- Labor-HHS Appropriations - CAR-T Therapy clarification - S. 4440/H.R. 3521, the Clinical Trial Modernization Act

Client expense: — · Firm income: $70,000

Matched citations: H.R. 3521

H.R. 3521119th Congress

Clinical Trial Modernization Act

2026 · second_quarter · Firm: SmithBucklin Corporation

Open original LDA filing ↗

Cited source text and reported amounts

Labor-HHS Appropriations Billing and Coding classifications CAR-T Therapy Clarifications H.R. 2491/S. 1227, Alleviating Barriers to Care Act H.R. 5160/S.4109, the Stem Cell Therapeutic and Research Reauthorization Act of 2025 H.R.1262/S.932, the Give Kids a Chance Act S. 4440/H.R. 3521 - The Clinical Trial Modernization Act

Client expense: — · Firm income: $70,000

Matched citations: H.R. 3521

H.R. 5160119th Congress

Stem Cell Therapeutic and Research Reauthorization Act of 2025

2026 · second_quarter · Firm: SmithBucklin Corporation

Open original LDA filing ↗

Cited source text and reported amounts

Labor-HHS Appropriations Billing and Coding classifications CAR-T Therapy Clarifications H.R. 2491/S. 1227, Alleviating Barriers to Care Act H.R. 5160/S.4109, the Stem Cell Therapeutic and Research Reauthorization Act of 2025 H.R.1262/S.932, the Give Kids a Chance Act S. 4440/H.R. 3521 - The Clinical Trial Modernization Act

Client expense: — · Firm income: $70,000

Matched citations: H.R. 5160

S. 1227119th Congress

ABC Act

2026 · second_quarter · Firm: SmithBucklin Corporation

Open original LDA filing ↗

Cited source text and reported amounts

Labor-HHS Appropriations Billing and Coding classifications CAR-T Therapy Clarifications H.R. 2491/S. 1227, Alleviating Barriers to Care Act H.R. 5160/S.4109, the Stem Cell Therapeutic and Research Reauthorization Act of 2025 H.R.1262/S.932, the Give Kids a Chance Act S. 4440/H.R. 3521 - The Clinical Trial Modernization Act

Client expense: — · Firm income: $70,000

Matched citations: S. 1227

S. 1227119th Congress

ABC Act

2026 · second_quarter · Firm: SmithBucklin Corporation

Open original LDA filing ↗

Cited source text and reported amounts

- CMS coding and billing clarity for CAR-T therapies - CMS engagement on MS-DRG 018 for CAR-T therapies - H.R. 2491/S. 1227, the Alleviating Barriers to Care Act

Client expense: — · Firm income: $70,000

Matched citations: S. 1227

S. 4109119th Congress

Stem Cell Therapeutic and Research Reauthorization Act of 2026

2026 · second_quarter · Firm: SmithBucklin Corporation

Open original LDA filing ↗

Cited source text and reported amounts

Labor-HHS Appropriations Billing and Coding classifications CAR-T Therapy Clarifications H.R. 2491/S. 1227, Alleviating Barriers to Care Act H.R. 5160/S.4109, the Stem Cell Therapeutic and Research Reauthorization Act of 2025 H.R.1262/S.932, the Give Kids a Chance Act S. 4440/H.R. 3521 - The Clinical Trial Modernization Act

Client expense: — · Firm income: $70,000

Matched citations: S.4109

S. 4440119th Congress

Clinical Trial Modernization Act

2026 · second_quarter · Firm: SmithBucklin Corporation

Open original LDA filing ↗

Cited source text and reported amounts

- Labor-HHS Appropriations - CAR-T Therapy clarification - S. 4440/H.R. 3521, the Clinical Trial Modernization Act

Client expense: — · Firm income: $70,000

Matched citations: S. 4440

S. 4440119th Congress

Clinical Trial Modernization Act

2026 · second_quarter · Firm: SmithBucklin Corporation

Open original LDA filing ↗

Cited source text and reported amounts

Labor-HHS Appropriations Billing and Coding classifications CAR-T Therapy Clarifications H.R. 2491/S. 1227, Alleviating Barriers to Care Act H.R. 5160/S.4109, the Stem Cell Therapeutic and Research Reauthorization Act of 2025 H.R.1262/S.932, the Give Kids a Chance Act S. 4440/H.R. 3521 - The Clinical Trial Modernization Act

Client expense: — · Firm income: $70,000

Matched citations: S. 4440

S. 932119th Congress

Give Kids a Chance Act of 2025

2026 · second_quarter · Firm: SmithBucklin Corporation

Open original LDA filing ↗

Cited source text and reported amounts

Labor-HHS Appropriations Billing and Coding classifications CAR-T Therapy Clarifications H.R. 2491/S. 1227, Alleviating Barriers to Care Act H.R. 5160/S.4109, the Stem Cell Therapeutic and Research Reauthorization Act of 2025 H.R.1262/S.932, the Give Kids a Chance Act S. 4440/H.R. 3521 - The Clinical Trial Modernization Act

Client expense: — · Firm income: $70,000

Matched citations: S.932

H.R. 1262119th Congress

Mikaela Naylon Give Kids a Chance Act

2026 · first_quarter · Firm: SmithBucklin Corporation

Open original LDA filing ↗

Cited source text and reported amounts

Labor-HHS Appropriations Billing and Coding classifications CAR-T Therapy Clarifications Revaccination of Immunosuppressed Patients H.R. 1509/S. 752, The Accelerating Kids Access to Care Act H.R. 2491/S. 1227, Alleviating Barriers to Care Act H.R. 5160/S.4109, the Stem Cell Therapeutic and Research Reauthorization Act of 2025 H.R.1262/S.932, the Give Kids a Chance Act

Client expense: — · Firm income: $70,000

Matched citations: H.R.1262

Source: Senate LDA

ASTCT — Lobbying Disclosure | Poliscope